Trial
NCT01790594
Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Clinical Trials in Organ Transplantation; Rho Federal Systems Division, Inc.; Bristol-Myers Squibb
Condition
Simultaneous Kidney and Pancreas Transplantation
Intervention
Belatacept
Why stopped
Slow accrual within enrollment time period: projected accrual goal not achieved.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-20